Does an extensive diagnostic workup for upfront resectable pancreatic cancer result in a delay which affects survival? Results from an international multicentre study.
Thomas Brendon RussellPeter Lawrence Zaki LabibJemimah DensonFabio AusaniaElizabeth PandoKeith J RobertsAmbareen KausarVasileios K MavroeidisGabriele MarangoniSarah C ThomassetAdam E FramptonPavlos LykoudisManuel MaglioneNassir AlhaboobHassaan BariAndrew M SmithDuncan SpaldingParthi SrinivasanBrian R DavidsonRicky H BhogalDaniel CroaghAshray RajagopalanIsmael DominguezRohan ThakkarDhanny GomezMichael A SilvaPierfrancesco LapollaAndrea MingoliAlberto PorcuTeresa PerraNehal S ShahZaed Z R HamadyBilal Al-SarriehAlejandro SerrabloSomaiah Aroorinull nullPublished in: Annals of hepato-biliary-pancreatic surgery (2023)
Although a treatment delay may give rise to patient anxiety, our findings would suggest this does not correlate with worse survival. A delay may be necessary to obtain further information and minimize the number of PD patients diagnosed with early disease recurrence.